Safety & side effects

What we know about safety, and the large gaps

In the short, controlled studies that exist, ipamorelin was well tolerated, with mostly mild and transient effects. That is genuinely reassuring as far as it goes. The problem is how far it goes: every human exposure on record was single-dose or lasted at most about a week.

This unit separates the reassuring short-term data from the real, mostly theoretical, longer-term concerns: blood sugar, IGF-1 and cancer-risk questions, the acromegaly-spectrum risks of chronic stimulation, who should avoid it, and what monitoring a cautious clinician would want. As always, this is education, not medical advice.